Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tsukada M et al. – Loss of CEACAM1 expression may reflect a high metastatic potential and thus indicate a poor prognosis for patients with hepatoblastoma.

Related Articles

Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge
Diagnostic Pathology, 11/17/09    Relevance Score: 87%

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09    Relevance Score: 87%

Long-term Treatment Results of Hepatoblastoma at a Single Institution in Taiwan
Journal of Pediatric Hematology/Oncology, 11/06/09    Relevance Score: 85%

Hepatoblastoma, cisplatin, and ototoxicity
Cancer, 10/12/09    Relevance Score: 83%

Today in Basic Science/Genetics...keeping you current

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung
Clinical Cancer Research, 12/14/09

17,18-EpETE Targets PPAR and p38MAPK to Mediate its Anti-Inflammatory Effect in Lung: Role of sEH
American Journal of Respiratory Cell and Molecular Biology, 12/14/09

Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis
Tuberculosis , 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address